Navigation Links
Protein regulates enzyme linked to Alzheimer's disease
Date:5/25/2010

BOSTON (May 25, 2010) Researchers at Tufts University School of Medicine have zeroed in on a protein that may play a role in the progression of Alzheimer's disease. The team found that increasing levels of the protein (called GGA3) prevented the accumulation of an enzyme linked to Alzheimer's. The strategy may lead to new treatments for the neurodegenerative disease. The findings were published online May 18 in the Journal of Biological Chemistry.

People with Alzheimer's disease typically have higher levels of an enzyme called BACE1 in their brains. BACE1 produces a toxin that researchers have pinpointed as a cause of Alzheimer's, and now, researchers have found a way to prevent BACE1 from accumulating in the brain.

"We have identified the protein that takes this enzyme to the cell's garbage disposal for removal. Increasing levels of the protein allows more of the enzyme to be eliminated, possibly preventing the high levels seen in people with Alzheimer's disease," said senior author Giuseppina Tesco, MD, PhD, assistant professor in the department of neuroscience at Tufts University School of Medicine (TUSM).

Tesco and colleagues previously discovered that levels of the GGA3 protein were significantly lower in the brains of Alzheimer's patients than those free of the disease. In the current in vitro study, the team also found, unexpectedly, that the GGA3 protein must bind with the regulatory protein ubiquitin in order to lower enzyme levels.

"This insight advances our understanding of the molecular mechanisms of Alzheimer's disease. We hope that our approach will lead to new therapies that treat and prevent Alzheimer's, which currently affects as many as 5.1 million Americans," said Tesco. Tesco is also a member of the neuroscience program faculty at the Sackler School of Graduate Biomedical Sciences at Tufts, leading the Alzheimer's disease research laboratory.

Alzheimer's disease is a progressive neurodegenerative disorder that results in loss of memory and cognitive function. It is the most common cause of dementia in adults age 65 and over. Currently, prescription drugs are available that may slow the progression of the disease, but none of these medications are effective in stopping the progression of Alzheimer's.


'/>"/>

Contact: Siobhan Gallagher
617-636-6586
Tufts University, Health Sciences
Source:Eurekalert

Related biology news :

1. Intracellular express -- why transport protein molecules have brakes
2. Protein power for Jack and the beanstalk
3. Study finds protein that plays key role in early embryonic development
4. Jefferson scientists identify a new protein involved in longevity
5. Dietary protein may reduce hip fractures in the elderly
6. Glaucomas unique protein expression could enhance diagnosis and treatment
7. AAPS presents therapeutic protein drug interactions workshop
8. Synthetic enzymes could help ID proteins
9. New data on the regulation of a protein that is altered in all cancers
10. Research pinpoints action of protein linked to key molecular switch
11. Hopkins researchers put proteins right where they want them
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2017)... UBM,s Advanced Design and Manufacturing event in ... and evolving technology through its 3D Printing and Smart ... the expo portion of the event and feature a ... on trending topics within 3D printing and smart manufacturing. ... will take place June 13-15, 2017 at the Jacob K. ...
(Date:4/11/2017)... , April 11, 2017 No ... but researchers at the New York University Tandon ... of Engineering have found that partial similarities between ... systems used in mobile phones and other electronic ... The vulnerability lies in the fact ...
(Date:4/5/2017)... -- Today HYPR Corp. , leading innovator in ... the HYPR platform is officially FIDO® Certified . ... that empowers biometric authentication across Fortune 500 enterprises and ... 15 million users across the financial services industry, however ... suites and physical access represent a growing portion of ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... Sciences today announced the three Winners and six Finalists of the 2017 Blavatnik ... annually by the Blavatnik Family Foundation and administered by the New York Academy ...
(Date:10/12/2017)... ... ... AMRI, a global contract research, development and manufacturing organization ... quality of life, will now be offering its impurity solutions as a stand-alone ... for all new drug products, including the finalization of ICH M7 earlier this ...
(Date:10/11/2017)... ... October 11, 2017 , ... Personal eye wash is a basic first aid supply for ... time. So which eye do you rinse first if a dangerous substance enters both eyes? ... Eye Wash with its unique dual eye piece. , “Whether its dirt and debris, ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
Breaking Biology Technology: